This inventor holds 1 USPTO granted patent. Top assignees: Medvet Science Pty Ltd, Novartis Ag. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 14 
1 out of 3,975 
Years Active: 2014
Title: The Innovative Contributions of Timothy P Hughes
Introduction
Timothy P Hughes is a notable inventor based in South Australia, Australia. He has made significant contributions to the field of medicine, particularly in the treatment of leukemia. His work has been recognized for its potential to improve patient outcomes in chronic myeloid leukemia.
Latest Patents
Hughes holds a patent for a method of optimizing the treatment of Philadelphia-positive leukemia with imatinib mesylate. This invention specifically addresses the treatment of Philadelphia-positive leukemia (Ph+ leukemia), including chronic myeloid leukemia (CML). The method involves a series of steps aimed at effectively treating patients suffering from this condition.
Career Highlights
Throughout his career, Timothy P Hughes has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Novartis AG and Medvet Science Pty Ltd. His experience in these organizations has contributed to his expertise in developing innovative treatment methods.
Collaborations
Hughes has collaborated with esteemed colleagues, including Yanfeng Wang and Thea Kalebic. These partnerships have played a crucial role in advancing his research and patent developments.
Conclusion
Timothy P Hughes is a distinguished inventor whose work in optimizing leukemia treatment has the potential to make a significant impact in the medical field. His contributions reflect a commitment to improving patient care and advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile